Exploring the Effects of Saorilao-4 on the Gut Microbiota of Pulmonary Fibrosis Model Rats Based on 16S rRNA Sequencing

Pulmonary fibrosis (PF) is a progressive and incurable lung disease for which treatment options are limited. Here, we aimed to conduct an exploratory study on the effects of the Mongolian medicine Saorilao-4 (SRL) on the gut microbiota structure, species abundance, and diversity of a rat PF model as well as the mechanisms underlying such effects.